ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2026

Programmed Cell Death Protein 1-Interleukin-2 Bispecific Agents for Cancer Therapy.

Chang Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.